Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy

NCT01215383 is registered in ClinicalTrials.gov with Ziv Hospital as lead sponsor.

NCT NCT01215383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01215383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy
Lead sponsor
Ziv Hospital
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2010
Completion date
Not reported
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, schizoaffective disorder, schizophrenia